HomeInsightsStock Comparison

Caplin Point Laboratories Ltd vs Vaishali Pharma Ltd Stock Comparison

Caplin Point Laboratories Ltd vs Vaishali Pharma Ltd Stock Comparison

Last Updated on: Jul 16, 2025

Key Highlights

  • The Latest Trading Price of Caplin Point Laboratories Ltd is ₹ 2070 as of 16 Jul 13:21.
  • The P/E Ratio of Caplin Point Laboratories Ltd changed from 9.9 on March 2020 to 21.9 on March 2024 . This represents a CAGR of 17.21% over 5 yearsThe P/E Ratio of Vaishali Pharma Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Caplin Point Laboratories Ltd changed from ₹ 2135 crore on March 2020 to ₹ 10003 crore on March 2024 . This represents a CAGR of 36.18% over 5 yearsThe Market Cap of Vaishali Pharma Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Caplin Point Laboratories Ltd for the Mar '25 is ₹ 528.27 crore as compare to the Dec '24 revenue of ₹ 524.32 crore. This represent the growth of 0.75% The revenue of Vaishali Pharma Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Caplin Point Laboratories Ltd for the Mar '25 is ₹ 193.88 crore as compare to the Dec '24 ebitda of ₹ 193.64 crore. This represent the growth of 0.12% The ebitda of Vaishali Pharma Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Caplin Point Laboratories Ltd changed from ₹ 104.23 crore to ₹ 145.28 crore over 8 quarters. This represents a CAGR of 18.06% The net profit of Vaishali Pharma Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Caplin Point Laboratories Ltd changed from 9.57 % on March 2020 to 13.39 % on March 2024 . This represents a CAGR of 6.95% over 5 yearsThe Dividend Payout of Vaishali Pharma Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Caplin Point Laboratories Ltd

  • Promoted by Mr. C. C. Paarthipan, Caplin Point Laboratories Limited was incorporated on April 16, 1990.
  • The Company is a fully integrated Pharma Company and is presently into the business of pharmaceuticals like producing, developing and marketing wide range of generic formulations and branded products and exporting to overseas market.
  • Its main research and development facilities are located in Tamil Nadu, India and has a manufacturing plant in Puducherry, India.
  • It has over 4000+ products registrations across the globe with over 650+ pharmaceutical formulations & over 36 therapeutic sections. Caplin markets a wide spectrum of pharmaceutical formulations and therapeutic segments in 23 countries.
  • In addition to LATAM and Africa, it is now serving the US, European Union and other regulated markets as well.

About Vaishali Pharma Ltd

  • Vaishali Pharma Limited was originally incorporated as a Private Limited Company with the name 'Vaishali Pharma Private Limited' on 25th, April 2008.
  • On July 01, 2008 the Company acquired the business of proprietorship concerns of its Promoter Mr. Atul Vasani viz.
  • M/s.
  • Vaishali Pharmachem through Business Assignment agreement.
  • Consequently, the business of said Proprietorship Firm merged into Vaishali Pharma Private Limited.

Caplin Point Laboratories Ltd News Hub

News

Caplin Point Laboratories announces acquisition of Triwin Pharma S.A DE C.V

Caplin Point Laboratories announced that the Company's wholly owned Subsidiary Caplin Poin...

Read more

04 Jun 2025 13:43

News

Board of Caplin Point Laboratories recommends dividend

Caplin Point Laboratories announced that the Board of Directors of the Company at its meet...

Read more

15 May 2025 14:05

News

Caplin Steriles receives USFDA approval for Haloperidol Decanoate Injection

Caplin Steriles (Caplin), a Subsidiary Company of Caplin Point Laboratories, has been gran...

Read more

14 May 2025 14:27

News

Caplin Point Labs subsidiary gets US FDA nod for schizophrenia treatment drug Haloperidol

The approved drug is a generic therapeutic equivalent version of the reference listed drug...

Read more

14 May 2025 13:20

News

Caplin Point Laboratories to conduct board meeting

Caplin Point Laboratories will hold a meeting of the Board of Directors of the Company on ...

Read more

08 May 2025 14:47

News

Caplin Point Laboratories to conduct board meeting

Caplin Point Laboratories will hold a meeting of the Board of Directors of the Company on ...

Read more

07 May 2025 17:18

Vaishali Pharma Ltd News Hub

News

Vaishali Pharma to convene board meeting

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 28 May 202...

Read more

26 May 2025 18:27

News

Vaishali Pharma announces board meeting date

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 6 February...

Read more

01 Feb 2025 13:50

News

Vaishali Pharma to conduct board meeting

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 28 January...

Read more

25 Jan 2025 10:31

News

Vaishali Pharma to hold board meeting

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 14 Novembe...

Read more

12 Nov 2024 10:39

News

Vaishali Pharma schedules board meeting

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 10 October...

Read more

09 Oct 2024 10:17

News

Vaishali Pharma to conduct board meeting

Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 3 October ...

Read more

25 Sep 2024 15:36

SWOT Analysis Of Caplin Point Laboratories Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Vaishali Pharma Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Caplin Point Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Vaishali Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Caplin Point Laboratories Ltd and Vaishali Pharma Ltd

Which company has a larger market capitalization, Caplin Point Laboratories Ltd or Vaishali Pharma Ltd?

Market cap of Caplin Point Laboratories Ltd is 15,732 Cr while Market cap of Vaishali Pharma Ltd is 134 Cr

What are the key factors driving the stock performance of Caplin Point Laboratories Ltd and Vaishali Pharma Ltd?

The stock performance of Caplin Point Laboratories Ltd and Vaishali Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Caplin Point Laboratories Ltd and Vaishali Pharma Ltd?

As of July 16, 2025, the Caplin Point Laboratories Ltd stock price is INR ₹2069.8. On the other hand, Vaishali Pharma Ltd stock price is INR ₹12.54.

How do dividend payouts of Caplin Point Laboratories Ltd and Vaishali Pharma Ltd compare?

To compare the dividend payouts of Caplin Point Laboratories Ltd and Vaishali Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions